These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15549499)

  • 1. Population prevalence of APOE, APOC3 and PPAR-alpha mutations associated to hypertriglyceridemia in French Canadians.
    Garenc C; Aubert S; Laroche J; Girouard J; Vohl MC; Bergeron J; Rousseau F; Julien P
    J Hum Genet; 2004; 49(12):691-700. PubMed ID: 15549499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common genomic variation in the APOC3 promoter associated with variation in plasma lipoproteins.
    Hegele RA; Connelly PW; Hanley AJ; Sun F; Harris SB; Zinman B
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2753-8. PubMed ID: 9409252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The APOC3 SstI polymorphism is weakly associated with sporadic Alzheimer's disease in a Chinese population.
    Sun Y; Shi J; Zhang S; Tang M; Han H; Guo Y; Ma C; Liu X; Li T
    Neurosci Lett; 2005 Jun; 380(3):219-22. PubMed ID: 15862889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic determinants of the response to bezafibrate treatment in the lower extremity arterial disease event reduction (LEADER) trial.
    Jamshidi Y; Flavell DM; Hawe E; MacCallum PK; Meade TW; Humphries SE
    Atherosclerosis; 2002 Jul; 163(1):183-92. PubMed ID: 12048138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene polymorphisms in the Quebec population: a risk to develop hypertriglyceridemia.
    Garenc C; Aubert S; Laroche J; Bergeron J; Gagné C; Rousseau F; Julien P
    Biochem Biophys Res Commun; 2006 Jun; 344(2):588-96. PubMed ID: 16630553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.
    Tarr PE; Taffé P; Bleiber G; Furrer H; Rotger M; Martinez R; Hirschel B; Battegay M; Weber R; Vernazza P; Bernasconi E; Darioli R; Rickenbach M; Ledergerber B; Telenti A;
    J Infect Dis; 2005 May; 191(9):1419-26. PubMed ID: 15809899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between apolipoprotein C3 gene polymorphisms and risk of coronary heart disease in a Han population in East China.
    Yu J; Huang J; Liang Y; Qin B; He S; Xiao J; Wang H; Zhong R
    Lipids Health Dis; 2011 Nov; 10():200. PubMed ID: 22054125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of SstI polymorphism of the apolipoprotein CIII gene and environmental factors on risks of hypertriglyceridemia in Taiwan aborigines.
    Huang MC; Wang TN; Liu YL; Pa TH; Tu HP; Huang YC; Chang WT; Ko YC
    Circ J; 2006 Aug; 70(8):1030-6. PubMed ID: 16864937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms.
    Dammerman M; Sandkuijl LA; Halaas JL; Chung W; Breslow JL
    Proc Natl Acad Sci U S A; 1993 May; 90(10):4562-6. PubMed ID: 8099442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haplotype analysis of the apolipoprotein E and apolipoprotein C1 loci in Portugal and São Tomé e Príncipe (Gulf of Guinea): linkage disequilibrium evidence that APOE*4 is the ancestral APOE allele.
    Seixas S; Trovoada MJ; Rocha J
    Hum Biol; 1999 Dec; 71(6):1001-8. PubMed ID: 10592690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of apolipoprotein E, peroxisome proliferator-activated receptor alpha and lipoprotein lipase gene mutations on the ability of fenofibrate to improve lipid profiles and reach clinical guideline targets among hypertriglyceridemic patients.
    Brisson D; Ledoux K; Bossé Y; St-Pierre J; Julien P; Perron P; Hudson TJ; Vohl MC; Gaudet D
    Pharmacogenetics; 2002 Jun; 12(4):313-20. PubMed ID: 12042669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides.
    Talmud PJ; Hawe E; Martin S; Olivier M; Miller GJ; Rubin EM; Pennacchio LA; Humphries SE
    Hum Mol Genet; 2002 Nov; 11(24):3039-46. PubMed ID: 12417525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between plasma lipid parameters and APOC3 genotypes in Brazilian subjects: effect of gender, smoking and APOE genotypes.
    Fiegenbaum M; de Andrade FM; Hutz MH
    Clin Chim Acta; 2007 May; 380(1-2):175-81. PubMed ID: 17367769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E and apolipoprotein CI polymorphisms in the Czech population: almost complete linkage disequilibrium of the less frequent alleles of both polymorphisms.
    Hubácek JA; Pitha J; Adámková V; Skodová Z; Lánská V; Poledne R
    Physiol Res; 2003; 52(2):195-200. PubMed ID: 12678662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population.
    Zeng Q; Dammerman M; Takada Y; Matsunaga A; Breslow JL; Sasaki J
    Hum Genet; 1995 Apr; 95(4):371-5. PubMed ID: 7705829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein concentrations in newborns are associated with allelic variations in their mothers.
    Descamps OS; Bruniaux M; Guilmot PF; Tonglet R; Heller FR
    Atherosclerosis; 2004 Feb; 172(2):287-98. PubMed ID: 15019539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic determination of plasma lipids and insulin in the Czech population.
    Hubacek JA; Waterworth DM; Poledne R; Pitha J; Skodová Z; Humphries SE; Talmud PJ
    Clin Biochem; 2001 Mar; 34(2):113-8. PubMed ID: 11311220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effects of the apolipoprotein E epsilon3/epsilon2/epsilon4, the cholesteryl ester transfer protein TaqIB, and the apolipoprotein C3 -482 C>T polymorphisms on their association with coronary artery disease.
    Muendlein A; Saely CH; Marte T; Schmid F; Koch L; Rein P; Langer P; Aczel S; Drexel H
    Atherosclerosis; 2008 Jul; 199(1):179-86. PubMed ID: 18289550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between APOA5 -1131T>C and APOE polymorphisms and their association with severe hypertriglyceridemia.
    Sousa MO; Alía P; Pintó X; Corbella E; Navarro MA
    Clin Chim Acta; 2008 Sep; 395(1-2):68-71. PubMed ID: 18549811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein C3 SstI polymorphism in the risk assessment of CAD.
    Chhabra S; Narang R; Lakshmy R; Vasisht S; Agarwal DP; Srivastava LM; Manchanda SC; Das N
    Mol Cell Biochem; 2004 Apr; 259(1-2):59-66. PubMed ID: 15124908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.